Source: Annual Congress 2010 - New insights into reactive oxygen species
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
U. Farkhutdinov, A. Mirchaidarov, S. Farkhutdinov (Ufa, Russian Federation). The effect of intravenous immunoglobulin on active oxygen forms production in patients with community acquired pneumonia. Eur Respir J 2010; 36: Suppl. 54, 3731

Member's Comments

No comment yet.

Related content which might interest you: The effect of intravenous immunoglobulin on oxygen-dependent metabolism of blood cells in patients with community acquired pneumonia Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Active oxygen forms and antioxidant blood status in patients with community acquired pneumonia and its combination with COPD Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Intravenous immunoglobulin in community acquired pneumonia Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 The role of procoagulant activity in patients with community acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Condition of cellular immunity in patients with prolonged course of community acquired pneumonia Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 The effect of levofloxacin on the production of active oxygen forms by blood cells Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 The usage of laferon in treatment of patients with community acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003 High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003 The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group Source: Eur Respir J 2007; 30: Suppl. 51, 548s Year: 2007 Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency Source: Eur Respir J 2004; 24: Suppl. 48, 357s Year: 2004 Serum levels of soluble forms of intracellular adhesion molecules in patients with community acquired pneumonia Source: Annual Congress 2008 - Airway infection and host defence Year: 2008 Effects of empirical antibacterial therapy on the degree of systemic inflammatory response in patients with severe community-acquired pneumonia (SCAP) Source: Eur Respir J 2003; 22: Suppl. 45, 2s Year: 2003 The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Pulmonary immunoglobulin E levels and the response to anti-immunoglobulin E antibody therapy in paediatric severe therapy resistant asthma Source: Annual Congress 2012 - Treating childhood asthma Year: 2012